Although chronic liver disease (CLD) constitutes a significant proportion of acute medical
admissions, it is not known how CLD influences venous thromboembolism (VTE) …

Introduction Patients with liver disease are at risk of venous thromboembolism (VTE);
however, little is understood regarding the safety and efficacy of VTE prophylaxis in patients …

BACKGROUND The incidence of venous thromboembolism (VTE) in chronic liver disease
(CLD) patients has been reported to be 0.5% to 6.3%. Studies report the use of …

Study Objective To evaluate the impact of pharmacologic venous thromboembolism (VTE)
prophylaxis on risk of hemorrhage while hospitalized in patients with chronic liver disease …

Background Hospitalized patients with cirrhosis are at increased risk for venous
thromboembolism (VTE). The benefits and risks of pharmacological thromboprohylaxis in …

Study Objective To determine whether pharmacologic prophylaxis for venous
thromboembolism (VTE) was associated with a decrease in the incidence of VTE or an …

Background: Venous thromboembolism (VTE) is a common complication seen during or
after hospitalization that manifests as deep venous thrombosis (DVT) and/or pulmonary …

Introduction There is a lack of evidence regarding the need for thromboprophylaxis in
hospitalized patients with liver disease. The purpose of this study was to evaluate the Padua …

BACKGROUND Patients with liver disease are concomitantly at increased risk of venous
thromboembolism (VTE) and bleeding events due to changes in the balance of pro-and anti …

Hospital‐associated venous thromboembolism (HA‐VTE) is a major cause of morbidity and
mortality and is internationally recognized as a significant patient safety issue. While …